nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—TACR3—iris—melanoma	0.107	0.933	CbGeAlD
Aprepitant—CYP1A2—Carmustine—melanoma	0.0971	0.198	CbGbCtD
Aprepitant—CYP1A2—Vemurafenib—melanoma	0.0768	0.157	CbGbCtD
Aprepitant—CYP3A4—Temozolomide—melanoma	0.0734	0.15	CbGbCtD
Aprepitant—CYP1A2—Dacarbazine—melanoma	0.0588	0.12	CbGbCtD
Aprepitant—CYP3A7—Docetaxel—melanoma	0.0472	0.0963	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0472	0.0963	CbGbCtD
Aprepitant—CYP3A4—Vemurafenib—melanoma	0.0402	0.0821	CbGbCtD
Aprepitant—CYP3A5—Docetaxel—melanoma	0.0354	0.0722	CbGbCtD
Aprepitant—CYP3A4—Docetaxel—melanoma	0.0138	0.0282	CbGbCtD
Aprepitant—TACR3—head—melanoma	0.00461	0.0404	CbGeAlD
Aprepitant—TACR1—head—melanoma	0.00179	0.0157	CbGeAlD
Aprepitant—TACR1—lymph node—melanoma	0.00125	0.011	CbGeAlD
Aprepitant—Eye disorder—Temozolomide—melanoma	0.000397	0.00171	CcSEcCtD
Aprepitant—Tinnitus—Temozolomide—melanoma	0.000396	0.00171	CcSEcCtD
Aprepitant—Malaise—Bleomycin—melanoma	0.000395	0.0017	CcSEcCtD
Aprepitant—Flushing—Temozolomide—melanoma	0.000394	0.0017	CcSEcCtD
Aprepitant—Cardiac disorder—Temozolomide—melanoma	0.000394	0.0017	CcSEcCtD
Aprepitant—Dizziness—Vemurafenib—melanoma	0.00039	0.00168	CcSEcCtD
Aprepitant—Alopecia—Carmustine—melanoma	0.000388	0.00167	CcSEcCtD
Aprepitant—Angiopathy—Temozolomide—melanoma	0.000385	0.00166	CcSEcCtD
Aprepitant—Mental disorder—Carmustine—melanoma	0.000385	0.00166	CcSEcCtD
Aprepitant—Immune system disorder—Temozolomide—melanoma	0.000384	0.00165	CcSEcCtD
Aprepitant—Mediastinal disorder—Temozolomide—melanoma	0.000383	0.00165	CcSEcCtD
Aprepitant—Erythema—Carmustine—melanoma	0.000383	0.00165	CcSEcCtD
Aprepitant—Malnutrition—Carmustine—melanoma	0.000383	0.00165	CcSEcCtD
Aprepitant—Cough—Bleomycin—melanoma	0.000383	0.00165	CcSEcCtD
Aprepitant—Chills—Temozolomide—melanoma	0.000381	0.00164	CcSEcCtD
Aprepitant—Dehydration—Docetaxel—melanoma	0.00038	0.00164	CcSEcCtD
Aprepitant—Ill-defined disorder—Dactinomycin—melanoma	0.000379	0.00163	CcSEcCtD
Aprepitant—Anaemia—Dactinomycin—melanoma	0.000378	0.00163	CcSEcCtD
Aprepitant—Vomiting—Vemurafenib—melanoma	0.000375	0.00162	CcSEcCtD
Aprepitant—Alopecia—Temozolomide—melanoma	0.000375	0.00162	CcSEcCtD
Aprepitant—Chest pain—Bleomycin—melanoma	0.000373	0.00161	CcSEcCtD
Aprepitant—Myalgia—Bleomycin—melanoma	0.000373	0.00161	CcSEcCtD
Aprepitant—Abdominal pain upper—Docetaxel—melanoma	0.000373	0.00161	CcSEcCtD
Aprepitant—Rash—Vemurafenib—melanoma	0.000372	0.0016	CcSEcCtD
Aprepitant—Mental disorder—Temozolomide—melanoma	0.000372	0.0016	CcSEcCtD
Aprepitant—Dermatitis—Vemurafenib—melanoma	0.000372	0.0016	CcSEcCtD
Aprepitant—Back pain—Carmustine—melanoma	0.00037	0.00159	CcSEcCtD
Aprepitant—Headache—Vemurafenib—melanoma	0.00037	0.00159	CcSEcCtD
Aprepitant—Erythema—Temozolomide—melanoma	0.00037	0.00159	CcSEcCtD
Aprepitant—Malnutrition—Temozolomide—melanoma	0.00037	0.00159	CcSEcCtD
Aprepitant—Breast disorder—Docetaxel—melanoma	0.000369	0.00159	CcSEcCtD
Aprepitant—Discomfort—Bleomycin—melanoma	0.000369	0.00159	CcSEcCtD
Aprepitant—Malaise—Dactinomycin—melanoma	0.000369	0.00159	CcSEcCtD
Aprepitant—Cramp muscle—Docetaxel—melanoma	0.000368	0.00158	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000368	0.00158	CcSEcCtD
Aprepitant—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000368	0.00158	CcSEcCtD
Aprepitant—Dysgeusia—Temozolomide—melanoma	0.000362	0.00156	CcSEcCtD
Aprepitant—Confusional state—Bleomycin—melanoma	0.000361	0.00155	CcSEcCtD
Aprepitant—Alanine aminotransferase increased—Docetaxel—melanoma	0.00036	0.00155	CcSEcCtD
Aprepitant—Tremor—Carmustine—melanoma	0.000358	0.00154	CcSEcCtD
Aprepitant—Oedema—Bleomycin—melanoma	0.000358	0.00154	CcSEcCtD
Aprepitant—Anaphylactic shock—Bleomycin—melanoma	0.000358	0.00154	CcSEcCtD
Aprepitant—Back pain—Temozolomide—melanoma	0.000358	0.00154	CcSEcCtD
Aprepitant—Infection—Bleomycin—melanoma	0.000355	0.00153	CcSEcCtD
Aprepitant—Anaemia—Carmustine—melanoma	0.000354	0.00152	CcSEcCtD
Aprepitant—Dysphagia—Docetaxel—melanoma	0.000353	0.00152	CcSEcCtD
Aprepitant—Nausea—Vemurafenib—melanoma	0.000351	0.00151	CcSEcCtD
Aprepitant—Thrombocytopenia—Bleomycin—melanoma	0.00035	0.00151	CcSEcCtD
Aprepitant—Myalgia—Dactinomycin—melanoma	0.000348	0.0015	CcSEcCtD
Aprepitant—Tremor—Temozolomide—melanoma	0.000346	0.00149	CcSEcCtD
Aprepitant—Discomfort—Dactinomycin—melanoma	0.000344	0.00148	CcSEcCtD
Aprepitant—Ill-defined disorder—Temozolomide—melanoma	0.000343	0.00148	CcSEcCtD
Aprepitant—Anaemia—Temozolomide—melanoma	0.000342	0.00147	CcSEcCtD
Aprepitant—Anorexia—Bleomycin—melanoma	0.000341	0.00147	CcSEcCtD
Aprepitant—Angioedema—Temozolomide—melanoma	0.000338	0.00146	CcSEcCtD
Aprepitant—Hypotension—Bleomycin—melanoma	0.000334	0.00144	CcSEcCtD
Aprepitant—Oedema—Dactinomycin—melanoma	0.000334	0.00144	CcSEcCtD
Aprepitant—Malaise—Temozolomide—melanoma	0.000333	0.00144	CcSEcCtD
Aprepitant—Convulsion—Carmustine—melanoma	0.000332	0.00143	CcSEcCtD
Aprepitant—Infection—Dactinomycin—melanoma	0.000331	0.00143	CcSEcCtD
Aprepitant—Hypertension—Carmustine—melanoma	0.00033	0.00142	CcSEcCtD
Aprepitant—Neutropenia—Docetaxel—melanoma	0.00033	0.00142	CcSEcCtD
Aprepitant—Palpitations—Temozolomide—melanoma	0.000327	0.00141	CcSEcCtD
Aprepitant—Thrombocytopenia—Dactinomycin—melanoma	0.000327	0.00141	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Bleomycin—melanoma	0.000326	0.0014	CcSEcCtD
Aprepitant—Chest pain—Carmustine—melanoma	0.000326	0.0014	CcSEcCtD
Aprepitant—Myalgia—Carmustine—melanoma	0.000326	0.0014	CcSEcCtD
Aprepitant—Anxiety—Carmustine—melanoma	0.000325	0.0014	CcSEcCtD
Aprepitant—Cough—Temozolomide—melanoma	0.000323	0.00139	CcSEcCtD
Aprepitant—Paraesthesia—Bleomycin—melanoma	0.000321	0.00138	CcSEcCtD
Aprepitant—Weight increased—Docetaxel—melanoma	0.000321	0.00138	CcSEcCtD
Aprepitant—Convulsion—Temozolomide—melanoma	0.00032	0.00138	CcSEcCtD
Aprepitant—Weight decreased—Docetaxel—melanoma	0.000319	0.00138	CcSEcCtD
Aprepitant—Hypertension—Temozolomide—melanoma	0.000319	0.00137	CcSEcCtD
Aprepitant—Dyspnoea—Bleomycin—melanoma	0.000319	0.00137	CcSEcCtD
Aprepitant—Anorexia—Dactinomycin—melanoma	0.000318	0.00137	CcSEcCtD
Aprepitant—Pneumonia—Docetaxel—melanoma	0.000316	0.00136	CcSEcCtD
Aprepitant—Confusional state—Carmustine—melanoma	0.000315	0.00136	CcSEcCtD
Aprepitant—Arthralgia—Temozolomide—melanoma	0.000315	0.00136	CcSEcCtD
Aprepitant—Myalgia—Temozolomide—melanoma	0.000315	0.00136	CcSEcCtD
Aprepitant—Infestation—Docetaxel—melanoma	0.000315	0.00136	CcSEcCtD
Aprepitant—Infestation NOS—Docetaxel—melanoma	0.000315	0.00136	CcSEcCtD
Aprepitant—Anxiety—Temozolomide—melanoma	0.000314	0.00135	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000313	0.00135	CcSEcCtD
Aprepitant—Oedema—Carmustine—melanoma	0.000312	0.00134	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000312	0.00134	CcSEcCtD
Aprepitant—Discomfort—Temozolomide—melanoma	0.000311	0.00134	CcSEcCtD
Aprepitant—Decreased appetite—Bleomycin—melanoma	0.000311	0.00134	CcSEcCtD
Aprepitant—Infection—Carmustine—melanoma	0.00031	0.00134	CcSEcCtD
Aprepitant—Acute coronary syndrome—Docetaxel—melanoma	0.00031	0.00134	CcSEcCtD
Aprepitant—Renal failure—Docetaxel—melanoma	0.000309	0.00133	CcSEcCtD
Aprepitant—Myocardial infarction—Docetaxel—melanoma	0.000308	0.00133	CcSEcCtD
Aprepitant—Neuropathy peripheral—Docetaxel—melanoma	0.000308	0.00133	CcSEcCtD
Aprepitant—Dry mouth—Temozolomide—melanoma	0.000308	0.00133	CcSEcCtD
Aprepitant—Stomatitis—Docetaxel—melanoma	0.000307	0.00132	CcSEcCtD
Aprepitant—Pain—Bleomycin—melanoma	0.000306	0.00132	CcSEcCtD
Aprepitant—Conjunctivitis—Docetaxel—melanoma	0.000306	0.00132	CcSEcCtD
Aprepitant—Thrombocytopenia—Carmustine—melanoma	0.000306	0.00132	CcSEcCtD
Aprepitant—Tachycardia—Carmustine—melanoma	0.000305	0.00131	CcSEcCtD
Aprepitant—Confusional state—Temozolomide—melanoma	0.000304	0.00131	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000304	0.00131	CcSEcCtD
Aprepitant—Oedema—Temozolomide—melanoma	0.000302	0.0013	CcSEcCtD
Aprepitant—Anaphylactic shock—Temozolomide—melanoma	0.000302	0.0013	CcSEcCtD
Aprepitant—Infection—Temozolomide—melanoma	0.0003	0.00129	CcSEcCtD
Aprepitant—Anorexia—Carmustine—melanoma	0.000298	0.00128	CcSEcCtD
Aprepitant—Nervous system disorder—Temozolomide—melanoma	0.000296	0.00127	CcSEcCtD
Aprepitant—Thrombocytopenia—Temozolomide—melanoma	0.000295	0.00127	CcSEcCtD
Aprepitant—Feeling abnormal—Bleomycin—melanoma	0.000295	0.00127	CcSEcCtD
Aprepitant—Skin disorder—Temozolomide—melanoma	0.000293	0.00126	CcSEcCtD
Aprepitant—Hypotension—Carmustine—melanoma	0.000292	0.00126	CcSEcCtD
Aprepitant—Hyperhidrosis—Temozolomide—melanoma	0.000292	0.00126	CcSEcCtD
Aprepitant—Decreased appetite—Dactinomycin—melanoma	0.00029	0.00125	CcSEcCtD
Aprepitant—Fatigue—Dactinomycin—melanoma	0.000288	0.00124	CcSEcCtD
Aprepitant—Anorexia—Temozolomide—melanoma	0.000288	0.00124	CcSEcCtD
Aprepitant—Pain—Dactinomycin—melanoma	0.000285	0.00123	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Carmustine—melanoma	0.000285	0.00123	CcSEcCtD
Aprepitant—Urticaria—Bleomycin—melanoma	0.000284	0.00122	CcSEcCtD
Aprepitant—Body temperature increased—Bleomycin—melanoma	0.000283	0.00122	CcSEcCtD
Aprepitant—Insomnia—Carmustine—melanoma	0.000282	0.00122	CcSEcCtD
Aprepitant—Hypoaesthesia—Docetaxel—melanoma	0.000281	0.00121	CcSEcCtD
Aprepitant—Paraesthesia—Carmustine—melanoma	0.00028	0.00121	CcSEcCtD
Aprepitant—Pharyngitis—Docetaxel—melanoma	0.00028	0.00121	CcSEcCtD
Aprepitant—Urinary tract disorder—Docetaxel—melanoma	0.000279	0.0012	CcSEcCtD
Aprepitant—Dyspnoea—Carmustine—melanoma	0.000278	0.0012	CcSEcCtD
Aprepitant—Somnolence—Carmustine—melanoma	0.000278	0.0012	CcSEcCtD
Aprepitant—Connective tissue disorder—Docetaxel—melanoma	0.000278	0.0012	CcSEcCtD
Aprepitant—Urethral disorder—Docetaxel—melanoma	0.000277	0.00119	CcSEcCtD
Aprepitant—Feeling abnormal—Dactinomycin—melanoma	0.000275	0.00118	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Temozolomide—melanoma	0.000275	0.00118	CcSEcCtD
Aprepitant—Insomnia—Temozolomide—melanoma	0.000273	0.00118	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dactinomycin—melanoma	0.000273	0.00118	CcSEcCtD
Aprepitant—Decreased appetite—Carmustine—melanoma	0.000271	0.00117	CcSEcCtD
Aprepitant—Paraesthesia—Temozolomide—melanoma	0.000271	0.00117	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Carmustine—melanoma	0.00027	0.00116	CcSEcCtD
Aprepitant—Dyspnoea—Temozolomide—melanoma	0.000269	0.00116	CcSEcCtD
Aprepitant—Somnolence—Temozolomide—melanoma	0.000268	0.00116	CcSEcCtD
Aprepitant—Erythema multiforme—Docetaxel—melanoma	0.000267	0.00115	CcSEcCtD
Aprepitant—Pain—Carmustine—melanoma	0.000267	0.00115	CcSEcCtD
Aprepitant—Constipation—Carmustine—melanoma	0.000267	0.00115	CcSEcCtD
Aprepitant—Dyspepsia—Temozolomide—melanoma	0.000266	0.00114	CcSEcCtD
Aprepitant—Eye disorder—Docetaxel—melanoma	0.000264	0.00114	CcSEcCtD
Aprepitant—Abdominal pain—Dactinomycin—melanoma	0.000264	0.00114	CcSEcCtD
Aprepitant—Body temperature increased—Dactinomycin—melanoma	0.000264	0.00114	CcSEcCtD
Aprepitant—Hypersensitivity—Bleomycin—melanoma	0.000264	0.00114	CcSEcCtD
Aprepitant—Decreased appetite—Temozolomide—melanoma	0.000262	0.00113	CcSEcCtD
Aprepitant—Flushing—Docetaxel—melanoma	0.000262	0.00113	CcSEcCtD
Aprepitant—Cardiac disorder—Docetaxel—melanoma	0.000262	0.00113	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Temozolomide—melanoma	0.000261	0.00112	CcSEcCtD
Aprepitant—Fatigue—Temozolomide—melanoma	0.00026	0.00112	CcSEcCtD
Aprepitant—Constipation—Temozolomide—melanoma	0.000258	0.00111	CcSEcCtD
Aprepitant—Pain—Temozolomide—melanoma	0.000258	0.00111	CcSEcCtD
Aprepitant—Feeling abnormal—Carmustine—melanoma	0.000257	0.00111	CcSEcCtD
Aprepitant—Asthenia—Bleomycin—melanoma	0.000257	0.00111	CcSEcCtD
Aprepitant—Angiopathy—Docetaxel—melanoma	0.000256	0.0011	CcSEcCtD
Aprepitant—Gastrointestinal pain—Carmustine—melanoma	0.000255	0.0011	CcSEcCtD
Aprepitant—Immune system disorder—Docetaxel—melanoma	0.000255	0.0011	CcSEcCtD
Aprepitant—Mediastinal disorder—Docetaxel—melanoma	0.000255	0.0011	CcSEcCtD
Aprepitant—Chills—Docetaxel—melanoma	0.000253	0.00109	CcSEcCtD
Aprepitant—Pruritus—Bleomycin—melanoma	0.000253	0.00109	CcSEcCtD
Aprepitant—Alopecia—Docetaxel—melanoma	0.00025	0.00108	CcSEcCtD
Aprepitant—Feeling abnormal—Temozolomide—melanoma	0.000249	0.00107	CcSEcCtD
Aprepitant—Mental disorder—Docetaxel—melanoma	0.000247	0.00107	CcSEcCtD
Aprepitant—Abdominal pain—Carmustine—melanoma	0.000247	0.00106	CcSEcCtD
Aprepitant—Body temperature increased—Carmustine—melanoma	0.000247	0.00106	CcSEcCtD
Aprepitant—Gastrointestinal pain—Temozolomide—melanoma	0.000247	0.00106	CcSEcCtD
Aprepitant—Malnutrition—Docetaxel—melanoma	0.000246	0.00106	CcSEcCtD
Aprepitant—Erythema—Docetaxel—melanoma	0.000246	0.00106	CcSEcCtD
Aprepitant—Hypersensitivity—Dactinomycin—melanoma	0.000246	0.00106	CcSEcCtD
Aprepitant—Dysgeusia—Docetaxel—melanoma	0.000241	0.00104	CcSEcCtD
Aprepitant—Urticaria—Temozolomide—melanoma	0.00024	0.00103	CcSEcCtD
Aprepitant—Asthenia—Dactinomycin—melanoma	0.000239	0.00103	CcSEcCtD
Aprepitant—Abdominal pain—Temozolomide—melanoma	0.000239	0.00103	CcSEcCtD
Aprepitant—Body temperature increased—Temozolomide—melanoma	0.000239	0.00103	CcSEcCtD
Aprepitant—Back pain—Docetaxel—melanoma	0.000238	0.00102	CcSEcCtD
Aprepitant—Muscle spasms—Docetaxel—melanoma	0.000236	0.00102	CcSEcCtD
Aprepitant—Hypersensitivity—Carmustine—melanoma	0.00023	0.000991	CcSEcCtD
Aprepitant—Diarrhoea—Dactinomycin—melanoma	0.000228	0.000983	CcSEcCtD
Aprepitant—Vomiting—Bleomycin—melanoma	0.000227	0.00098	CcSEcCtD
Aprepitant—Anaemia—Docetaxel—melanoma	0.000227	0.000979	CcSEcCtD
Aprepitant—Rash—Bleomycin—melanoma	0.000226	0.000971	CcSEcCtD
Aprepitant—Dermatitis—Bleomycin—melanoma	0.000225	0.000971	CcSEcCtD
Aprepitant—Asthenia—Carmustine—melanoma	0.000224	0.000965	CcSEcCtD
Aprepitant—Hypersensitivity—Temozolomide—melanoma	0.000222	0.000958	CcSEcCtD
Aprepitant—Syncope—Docetaxel—melanoma	0.000221	0.00095	CcSEcCtD
Aprepitant—Palpitations—Docetaxel—melanoma	0.000217	0.000936	CcSEcCtD
Aprepitant—Asthenia—Temozolomide—melanoma	0.000217	0.000933	CcSEcCtD
Aprepitant—Loss of consciousness—Docetaxel—melanoma	0.000216	0.000931	CcSEcCtD
Aprepitant—Cough—Docetaxel—melanoma	0.000215	0.000924	CcSEcCtD
Aprepitant—Diarrhoea—Carmustine—melanoma	0.000214	0.00092	CcSEcCtD
Aprepitant—Pruritus—Temozolomide—melanoma	0.000214	0.00092	CcSEcCtD
Aprepitant—Convulsion—Docetaxel—melanoma	0.000213	0.000918	CcSEcCtD
Aprepitant—Nausea—Bleomycin—melanoma	0.000212	0.000915	CcSEcCtD
Aprepitant—Hypertension—Docetaxel—melanoma	0.000212	0.000914	CcSEcCtD
Aprepitant—Vomiting—Dactinomycin—melanoma	0.000212	0.000914	CcSEcCtD
Aprepitant—Rash—Dactinomycin—melanoma	0.00021	0.000906	CcSEcCtD
Aprepitant—Arthralgia—Docetaxel—melanoma	0.000209	0.000902	CcSEcCtD
Aprepitant—Chest pain—Docetaxel—melanoma	0.000209	0.000902	CcSEcCtD
Aprepitant—Myalgia—Docetaxel—melanoma	0.000209	0.000902	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000208	0.000895	CcSEcCtD
Aprepitant—Dizziness—Carmustine—melanoma	0.000206	0.000889	CcSEcCtD
Aprepitant—Diarrhoea—Temozolomide—melanoma	0.000206	0.000889	CcSEcCtD
Aprepitant—Dry mouth—Docetaxel—melanoma	0.000205	0.000882	CcSEcCtD
Aprepitant—Confusional state—Docetaxel—melanoma	0.000202	0.000872	CcSEcCtD
Aprepitant—Anaphylactic shock—Docetaxel—melanoma	0.000201	0.000864	CcSEcCtD
Aprepitant—Oedema—Docetaxel—melanoma	0.000201	0.000864	CcSEcCtD
Aprepitant—Dizziness—Temozolomide—melanoma	0.0002	0.000859	CcSEcCtD
Aprepitant—Infection—Docetaxel—melanoma	0.000199	0.000859	CcSEcCtD
Aprepitant—Vomiting—Carmustine—melanoma	0.000199	0.000855	CcSEcCtD
Aprepitant—Nausea—Dactinomycin—melanoma	0.000198	0.000854	CcSEcCtD
Aprepitant—Shock—Docetaxel—melanoma	0.000197	0.00085	CcSEcCtD
Aprepitant—Rash—Carmustine—melanoma	0.000197	0.000848	CcSEcCtD
Aprepitant—Nervous system disorder—Docetaxel—melanoma	0.000197	0.000848	CcSEcCtD
Aprepitant—Dermatitis—Carmustine—melanoma	0.000197	0.000847	CcSEcCtD
Aprepitant—Thrombocytopenia—Docetaxel—melanoma	0.000196	0.000846	CcSEcCtD
Aprepitant—Tachycardia—Docetaxel—melanoma	0.000196	0.000844	CcSEcCtD
Aprepitant—Headache—Carmustine—melanoma	0.000196	0.000843	CcSEcCtD
Aprepitant—Skin disorder—Docetaxel—melanoma	0.000195	0.00084	CcSEcCtD
Aprepitant—Vomiting—Temozolomide—melanoma	0.000192	0.000826	CcSEcCtD
Aprepitant—Anorexia—Docetaxel—melanoma	0.000191	0.000824	CcSEcCtD
Aprepitant—Rash—Temozolomide—melanoma	0.00019	0.000819	CcSEcCtD
Aprepitant—Dermatitis—Temozolomide—melanoma	0.00019	0.000819	CcSEcCtD
Aprepitant—Headache—Temozolomide—melanoma	0.000189	0.000814	CcSEcCtD
Aprepitant—Hypotension—Docetaxel—melanoma	0.000188	0.000808	CcSEcCtD
Aprepitant—Nausea—Carmustine—melanoma	0.000185	0.000799	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Docetaxel—melanoma	0.000183	0.000787	CcSEcCtD
Aprepitant—Insomnia—Docetaxel—melanoma	0.000182	0.000782	CcSEcCtD
Aprepitant—Paraesthesia—Docetaxel—melanoma	0.00018	0.000776	CcSEcCtD
Aprepitant—Nausea—Temozolomide—melanoma	0.000179	0.000772	CcSEcCtD
Aprepitant—Dyspnoea—Docetaxel—melanoma	0.000179	0.000771	CcSEcCtD
Aprepitant—Somnolence—Docetaxel—melanoma	0.000178	0.000768	CcSEcCtD
Aprepitant—Dyspepsia—Docetaxel—melanoma	0.000177	0.000761	CcSEcCtD
Aprepitant—Decreased appetite—Docetaxel—melanoma	0.000174	0.000751	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Docetaxel—melanoma	0.000173	0.000746	CcSEcCtD
Aprepitant—Fatigue—Docetaxel—melanoma	0.000173	0.000745	CcSEcCtD
Aprepitant—Constipation—Docetaxel—melanoma	0.000172	0.000739	CcSEcCtD
Aprepitant—Pain—Docetaxel—melanoma	0.000172	0.000739	CcSEcCtD
Aprepitant—Feeling abnormal—Docetaxel—melanoma	0.000165	0.000712	CcSEcCtD
Aprepitant—Gastrointestinal pain—Docetaxel—melanoma	0.000164	0.000707	CcSEcCtD
Aprepitant—Abdominal pain—Docetaxel—melanoma	0.000159	0.000683	CcSEcCtD
Aprepitant—Body temperature increased—Docetaxel—melanoma	0.000159	0.000683	CcSEcCtD
Aprepitant—Hypersensitivity—Docetaxel—melanoma	0.000148	0.000637	CcSEcCtD
Aprepitant—Asthenia—Docetaxel—melanoma	0.000144	0.00062	CcSEcCtD
Aprepitant—Pruritus—Docetaxel—melanoma	0.000142	0.000612	CcSEcCtD
Aprepitant—Diarrhoea—Docetaxel—melanoma	0.000137	0.000591	CcSEcCtD
Aprepitant—Dizziness—Docetaxel—melanoma	0.000133	0.000572	CcSEcCtD
Aprepitant—Vomiting—Docetaxel—melanoma	0.000128	0.00055	CcSEcCtD
Aprepitant—Rash—Docetaxel—melanoma	0.000127	0.000545	CcSEcCtD
Aprepitant—Dermatitis—Docetaxel—melanoma	0.000126	0.000544	CcSEcCtD
Aprepitant—Headache—Docetaxel—melanoma	0.000126	0.000541	CcSEcCtD
Aprepitant—Nausea—Docetaxel—melanoma	0.000119	0.000513	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—MAPK3—melanoma	2.52e-05	0.000154	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PIK3CA—melanoma	2.52e-05	0.000154	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC6A11—melanoma	2.52e-05	0.000154	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIP4K2A—melanoma	2.52e-05	0.000154	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ACER3—melanoma	2.5e-05	0.000152	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BRAF—melanoma	2.48e-05	0.000151	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTAP—melanoma	2.45e-05	0.000149	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLCB4—melanoma	2.44e-05	0.000149	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—melanoma	2.44e-05	0.000149	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IGF1—melanoma	2.41e-05	0.000147	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—MAPK1—melanoma	2.4e-05	0.000147	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—EGFR—melanoma	2.4e-05	0.000147	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	2.39e-05	0.000146	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.39e-05	0.000146	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAP2K1—melanoma	2.33e-05	0.000142	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—HRAS—melanoma	2.33e-05	0.000142	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CD—melanoma	2.32e-05	0.000141	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—PIK3CA—melanoma	2.29e-05	0.00014	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIP4K2A—melanoma	2.29e-05	0.00014	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC6A11—melanoma	2.29e-05	0.00014	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—UGT2B10—melanoma	2.28e-05	0.000139	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—KRAS—melanoma	2.27e-05	0.000138	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP17A1—melanoma	2.26e-05	0.000138	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—melanoma	2.23e-05	0.000136	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTAP—melanoma	2.23e-05	0.000136	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FGF2—melanoma	2.22e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	2.21e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PHGDH—melanoma	2.18e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LUM—melanoma	2.18e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.18e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PLA2G6—melanoma	2.16e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HPSE—melanoma	2.14e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GNA11—melanoma	2.14e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HS3ST5—melanoma	2.12e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CUBN—melanoma	2.1e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—FASN—melanoma	2.09e-05	0.000128	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLCB4—melanoma	2.08e-05	0.000127	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PIK3CA—melanoma	2.08e-05	0.000127	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MDM2—melanoma	2.08e-05	0.000127	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—AKT1—melanoma	2.06e-05	0.000126	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SLC5A5—melanoma	2.06e-05	0.000126	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ERBB2—melanoma	2.05e-05	0.000125	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	2.05e-05	0.000125	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BSG—melanoma	2.03e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CSPG4—melanoma	2.03e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SDHD—melanoma	2.03e-05	0.000124	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CB—melanoma	2.02e-05	0.000123	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PHGDH—melanoma	1.99e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LUM—melanoma	1.99e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GNAQ—melanoma	1.99e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CD44—melanoma	1.99e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPAM—melanoma	1.96e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC6A11—melanoma	1.96e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIP4K2A—melanoma	1.96e-05	0.00012	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HPSE—melanoma	1.95e-05	0.000119	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL8—melanoma	1.94e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—VCAN—melanoma	1.94e-05	0.000118	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—HRAS—melanoma	1.93e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CUBN—melanoma	1.91e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTAP—melanoma	1.91e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CYP1B1—melanoma	1.91e-05	0.000116	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1B—melanoma	1.9e-05	0.000116	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—AKT1—melanoma	1.87e-05	0.000114	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.86e-05	0.000114	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CASP3—melanoma	1.86e-05	0.000113	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SDHD—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BSG—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CSPG4—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCND1—melanoma	1.81e-05	0.00011	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPAM—melanoma	1.79e-05	0.000109	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CTNNB1—melanoma	1.79e-05	0.000109	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—melanoma	1.76e-05	0.000107	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDKN1A—melanoma	1.75e-05	0.000107	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTEN—melanoma	1.74e-05	0.000107	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFKB1—melanoma	1.74e-05	0.000106	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AKT1—melanoma	1.7e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PHGDH—melanoma	1.7e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LUM—melanoma	1.7e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLA2G6—melanoma	1.67e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HPSE—melanoma	1.67e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP17A1—melanoma	1.64e-05	9.99e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CUBN—melanoma	1.64e-05	9.99e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLCB4—melanoma	1.61e-05	9.82e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CSPG4—melanoma	1.58e-05	9.65e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SDHD—melanoma	1.58e-05	9.65e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BSG—melanoma	1.58e-05	9.65e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—melanoma	1.58e-05	9.62e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCB1—melanoma	1.57e-05	9.58e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT3—melanoma	1.56e-05	9.53e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NRAS—melanoma	1.56e-05	9.5e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GNA11—melanoma	1.55e-05	9.44e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPAM—melanoma	1.53e-05	9.34e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLA2G6—melanoma	1.52e-05	9.29e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC6A11—melanoma	1.51e-05	9.23e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIP4K2A—melanoma	1.51e-05	9.23e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—FASN—melanoma	1.51e-05	9.23e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—VCAN—melanoma	1.5e-05	9.16e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK3—melanoma	1.49e-05	9.1e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC5A5—melanoma	1.49e-05	9.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTAP—melanoma	1.47e-05	8.98e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MYC—melanoma	1.45e-05	8.85e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PRKCA—melanoma	1.44e-05	8.82e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GNAQ—melanoma	1.44e-05	8.77e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CD44—melanoma	1.44e-05	8.77e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ERCC2—melanoma	1.43e-05	8.75e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.42e-05	8.67e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK1—melanoma	1.42e-05	8.66e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EGFR—melanoma	1.42e-05	8.66e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CYP1B1—melanoma	1.38e-05	8.41e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.37e-05	8.37e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—VCAN—melanoma	1.37e-05	8.35e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—KRAS—melanoma	1.34e-05	8.18e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LUM—melanoma	1.31e-05	8.01e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PHGDH—melanoma	1.31e-05	8.01e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLA2G6—melanoma	1.3e-05	7.94e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.29e-05	7.9e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HPSE—melanoma	1.29e-05	7.85e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP17A1—melanoma	1.27e-05	7.73e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CUBN—melanoma	1.26e-05	7.71e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.25e-05	7.63e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.25e-05	7.62e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.23e-05	7.52e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CA—melanoma	1.23e-05	7.51e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SDHD—melanoma	1.22e-05	7.44e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CSPG4—melanoma	1.22e-05	7.44e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BSG—melanoma	1.22e-05	7.44e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GNA11—melanoma	1.2e-05	7.3e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—melanoma	1.19e-05	7.27e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPAM—melanoma	1.18e-05	7.21e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—FASN—melanoma	1.17e-05	7.14e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—VCAN—melanoma	1.17e-05	7.13e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP17A1—melanoma	1.15e-05	7.04e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC5A5—melanoma	1.15e-05	7.02e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—HRAS—melanoma	1.14e-05	6.95e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.14e-05	6.95e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCB1—melanoma	1.13e-05	6.93e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CG—melanoma	1.13e-05	6.91e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.12e-05	6.86e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GNAQ—melanoma	1.11e-05	6.78e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CD44—melanoma	1.11e-05	6.78e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.11e-05	6.75e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—melanoma	1.09e-05	6.67e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—melanoma	1.09e-05	6.65e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GNA11—melanoma	1.09e-05	6.65e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.09e-05	6.64e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.08e-05	6.58e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.07e-05	6.52e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—FASN—melanoma	1.07e-05	6.51e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CYP1B1—melanoma	1.07e-05	6.5e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC5A5—melanoma	1.05e-05	6.4e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PRKCA—melanoma	1.04e-05	6.37e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ERCC2—melanoma	1.04e-05	6.32e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GNAQ—melanoma	1.01e-05	6.18e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CD44—melanoma	1.01e-05	6.18e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—melanoma	1.01e-05	6.14e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLA2G6—melanoma	1e-05	6.13e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CD—melanoma	9.95e-06	6.07e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.92e-06	6.06e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP17A1—melanoma	9.86e-06	6.02e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.83e-06	6e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—melanoma	9.82e-06	5.99e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.73e-06	5.94e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP1B1—melanoma	9.71e-06	5.93e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	9.6e-06	5.86e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.4e-06	5.74e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GNA11—melanoma	9.31e-06	5.68e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FASN—melanoma	9.11e-06	5.56e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—VCAN—melanoma	9.02e-06	5.51e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC5A5—melanoma	8.96e-06	5.47e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCB1—melanoma	8.77e-06	5.35e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CB—melanoma	8.67e-06	5.29e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GNAQ—melanoma	8.66e-06	5.28e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CD44—melanoma	8.66e-06	5.28e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—melanoma	8.59e-06	5.24e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.57e-06	5.23e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.48e-06	5.17e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.4e-06	5.13e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP1B1—melanoma	8.3e-06	5.07e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CG—melanoma	8.18e-06	4.99e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PRKCA—melanoma	8.07e-06	4.93e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ERCC2—melanoma	8.01e-06	4.89e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCB1—melanoma	8e-06	4.88e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—melanoma	7.89e-06	4.82e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP17A1—melanoma	7.61e-06	4.65e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTEN—melanoma	7.49e-06	4.57e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PRKCA—melanoma	7.36e-06	4.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.33e-06	4.47e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ERCC2—melanoma	7.3e-06	4.46e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CD—melanoma	7.19e-06	4.39e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GNA11—melanoma	7.19e-06	4.39e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—melanoma	7.1e-06	4.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FASN—melanoma	7.03e-06	4.29e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC5A5—melanoma	6.92e-06	4.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCB1—melanoma	6.83e-06	4.17e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GNAQ—melanoma	6.68e-06	4.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CD44—melanoma	6.68e-06	4.08e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.63e-06	4.05e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP1B1—melanoma	6.41e-06	3.91e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CG—melanoma	6.32e-06	3.86e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PRKCA—melanoma	6.29e-06	3.84e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CB—melanoma	6.27e-06	3.83e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ERCC2—melanoma	6.24e-06	3.81e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—melanoma	6.21e-06	3.79e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—melanoma	6.1e-06	3.73e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.05e-06	3.69e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CG—melanoma	5.77e-06	3.52e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—melanoma	5.56e-06	3.4e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CD—melanoma	5.56e-06	3.39e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—melanoma	5.49e-06	3.35e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTEN—melanoma	5.42e-06	3.31e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CA—melanoma	5.29e-06	3.23e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCB1—melanoma	5.27e-06	3.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.17e-06	3.15e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CD—melanoma	5.07e-06	3.09e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—melanoma	5e-06	3.05e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CG—melanoma	4.93e-06	3.01e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PRKCA—melanoma	4.85e-06	2.96e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CB—melanoma	4.85e-06	2.96e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ERCC2—melanoma	4.81e-06	2.94e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—melanoma	4.8e-06	2.93e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—melanoma	4.76e-06	2.9e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CB—melanoma	4.42e-06	2.7e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—melanoma	4.38e-06	2.67e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CD—melanoma	4.33e-06	2.64e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—melanoma	4.32e-06	2.64e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—melanoma	4.28e-06	2.61e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTEN—melanoma	4.19e-06	2.56e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CA—melanoma	3.82e-06	2.33e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTEN—melanoma	3.82e-06	2.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CG—melanoma	3.8e-06	2.32e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CB—melanoma	3.78e-06	2.3e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—melanoma	3.74e-06	2.28e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—melanoma	3.67e-06	2.24e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CD—melanoma	3.34e-06	2.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—melanoma	3.3e-06	2.01e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTEN—melanoma	3.26e-06	1.99e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—melanoma	3.12e-06	1.91e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CA—melanoma	2.95e-06	1.8e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CB—melanoma	2.91e-06	1.78e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—melanoma	2.89e-06	1.76e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CA—melanoma	2.69e-06	1.64e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTEN—melanoma	2.52e-06	1.54e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—melanoma	2.41e-06	1.47e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CA—melanoma	2.3e-06	1.4e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—melanoma	2.2e-06	1.34e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—melanoma	1.88e-06	1.15e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CA—melanoma	1.78e-06	1.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—melanoma	1.45e-06	8.86e-06	CbGpPWpGaD
